Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hoechst/Andrx Cardizem CD Settlement Is Antitrust Violation - Biovail

Executive Summary

Hoechst Marion Roussel's settlement with Andrx over a generic version of Cardizem CD is part of a pattern of antitrust violations by Hoechst, Biovail claimed in a March 30 suit filed in Newark, N.J. federal court.

You may also be interested in...



Aventis/Andrx Cardizem CD Deal Violated Antitrust Laws, Judge Says

Andrx and Aventis violated federal antitrust laws by entering an agreement aimed to keep all generic Cardizem CD products off the market, a June 6 Detroit federal court summary judgement maintains.

Aventis/Andrx Cardizem CD Deal Violated Antitrust Laws, Judge Says

Andrx and Aventis violated federal antitrust laws by entering an agreement aimed to keep all generic Cardizem CD products off the market, a June 6 Detroit federal court summary judgement maintains.

FTC Hytrin Order Clears Path For Four Generics; Cardizem CD Case Filed

Geneva's settlement with the Federal Trade Commission regarding generic terazosin (Hytrin) could open up the market for up to four new entrants.

UsernamePublicRestriction

Register

PS017586

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel